← back to search

Yu Zhang

Guangzhou University of Chinese Medicine · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, Epigenetics and DNA Methylation, and Cancer-related molecular mechanisms research.
h-index
38
citations
5,448
works
202
NIH funding
primary concept
email

Recent publications

Comparative study of mouse models of atopic dermatitis
Heliyon 2025cited by 9position: middledoi
Fecal microbiota transplantation against moderate‐to‐severe atopic dermatitis: A randomized, double‐blind controlled explorer trial
Allergy 2024cited by 20position: middledoi
Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER
Radiation Oncology 2024cited by 10position: middledoi
The triglyceride-glucose index dynamic trajectory reveals the association between the clinical subphenotype of insulin resistance and mortality in patients with sepsis
BMC Infectious Diseases 2024cited by 8position: middledoi
Nuclear-cytoplasmic translocation of SQSTM1/p62 protein enhances ESCC cell migration and invasion by stabilizing EPLIN expression.
2024cited by 5position: contributordoi
Tenascin-C as a potential biomarker and therapeutic target for esophageal squamous cell carcinoma.
2024cited by 4position: contributordoi
Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis
Journal of Autoimmunity 2023cited by 24position: middledoi
Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC.
2023cited by 2position: contributordoi
DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer.
2022cited by 15position: contributordoi
Therapeutic effect of chinese herbal medicine gu-ben-hua-shi (AESS) formula on atopic dermatitis through regulation of yes-associated protein
Frontiers in Pharmacology 2022cited by 7position: middledoi
Hypoxia‐induced FOXO4/LDHA axis modulates gastric cancer cell glycolysis and progression
Clinical and Translational Medicine 2021cited by 77position: middledoi
Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1–AKT axis-mediated glycolysis
Cell Death and Disease 2020cited by 80position: middledoi
Over‐expression of TFB2M facilitates cell growth and metastasis via activating ROS‐Akt‐NF‐κB signalling in hepatocellular carcinoma
Liver International 2020cited by 33position: middledoi
Prognostic role of aberrant mTOR activation in patients with stage II and III colorectal cancer.
2020cited by 3position: contributordoi
Two novel 1,4‑naphthoquinone derivatives induce human gastric cancer cell apoptosis and cell cycle arrest by regulating reactive oxygen species‑mediated MAPK/Akt/STAT3 signaling pathways
Molecular Medicine Reports 2019cited by 30position: middledoi
Safety and efficacy of ex vivo expanded CD34+ stem cells in murine and primate models
Stem Cell Research & Therapy 2019cited by 22position: firstdoi
New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways
Chemico-Biological Interactions 2019cited by 20position: middledoi
Novel 1,4‑naphthoquinone derivatives induce reactive oxygen species‑mediated apoptosis in liver cancer cells
Molecular Medicine Reports 2018cited by 25position: middledoi
GINS complex subunit 2 (GINS2) plays a protective role in alcohol-induced brain injury
Artificial Cells Nanomedicine and Biotechnology 2018cited by 14position: lastdoi
Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma
Nature Genetics 2016cited by 280position: middledoi
Genomic and molecular characterization of esophageal squamous cell carcinoma
Nature Genetics 2014cited by 662position: middledoi
Arsenic trioxide exerts a double effect on osteoblast growth in vitro
Environmental Toxicology and Pharmacology 2014cited by 15position: middledoi
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway
Leukemia 2013cited by 50position: middledoi
Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors
BMC Cancer 2012cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2020–2024)Ming‐Rong Wang · Fujian Medical University4 papers (2012–2024) · 3 papers (2018–2019)Jia‐Jie Hao · Hunan University3 papers (2012–2016) · 3 papers (2018–2019)Xian‐Ji Piao · Harbin Medical University3 papers (2018–2019)Wanting Xu · Anhui Medical University3 papers (2018–2019)Zhi‐Zhou Shi · Kunming University of Science and Technology3 papers (2012–2016)Cheng‐Hao Jin · Nanchang University3 papers (2018–2019)Wenqiang Wei · Sun Yat-sen University3 papers (2016–2024)Shinong Wang · University of California, Los Angeles3 papers (2018–2019)Changyuan Wang · Jiangsu University2 papers (2019–2019)Qimin Zhan · Beijing National Laboratory for Molecular Sciences2 papers (2012–2016)Siqi Ye · Guangzhou University of Chinese Medicine2 papers (2022–2025)Yang Luo · Shanghai Medical Information Center2 papers (2023–2024)Yan‐Yi Jiang · Second Hospital of Anhui Medical University2 papers (2014–2016)Jinjing Jia · Guangzhou University of Chinese Medicine2 papers (2022–2025) · 2 papers (2018–2019)Li-Yan Yang · 2 papers (2024–2024) · 2 papers (2018–2019)